Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC   US23254L3069

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2015 04/14/2015 04/15/2015 04/16/2015 04/17/2015 Date
1.05(c) 1.08(c) 1.04(c) 1.02(c) 1.01(c) Last
2 245 934 2 101 173 884 296 298 938 222 964 Volume
+12.92% +2.86% -3.70% -1.92% -0.98% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -31,9 M
Net income 2015 -28,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 -
EBIT 2016 -35,1 M
Net income 2016 -35,1 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 0
Capitalization 34,7 M
More Financials
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
Sector
Biotechnology & Medical Research
Calendar
04/20 | 08:00amPresentation
More about the company
Latest news on CYCLACEL PHARMACEUTICALS I
03/25 CYCLACEL PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2014 Financial R..
03/24 CYCLACEL PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
03/24 Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial ..
03/20 Cyclacel's CYC065 Featured in Presentations at the American Association for C..
03/18 CYCLACEL PHARMACEUTICALS : to Release Fourth Quarter and Full Year 2014 Financia..
03/17 Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2014 Financi..
03/05 CYCLACEL PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
03/04 CYCLACEL PHARMACEUTICALS : Entry into a Material Definitive Agreement, Other Eve..
More news
Sector news : Bio Therapeutic Drugs
04/17 INCYTE : Emerging Development Pipeline Described in Eleven Abstracts at 2015 AAC..
04/16 QIAGEN NV : N.V. : to Report First Quarter 2015 Results
04/16 Receptos Reports Positive Results for the Maintenance Period of the Phase 2 T..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/15 Midday Gainers / Losers
03/25 Cyclacel Pharma ups revenues 55% in FY14
03/24 Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q4 2014 Results - Earn..
03/24 Cyclacel Pharmaceuticals beats by $0.05
03/20 NEXT WEEK IN BIOTECH : Pediatric Safety Ad Comm, BIO Asia, Sinovac Earnings


Comments 
Advertisement
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF